Drug Shortage Report for APO-DIVALPROEX
Report ID | 156990 |
Drug Identification Number | 02239700 |
Brand name | APO-DIVALPROEX |
Common or Proper name | DIVALPROEX |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | VALPROIC ACID |
Strength(s) | 500MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | N03AG |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-03-15 |
Estimated end date | 2022-10-07 |
Actual end date | 2022-09-29 |
Shortage status | Resolved |
Updated date | 2022-09-30 |
Company comments | Batches continue to be released and limited inventory is available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v28 | 2022-09-30 | French | Compare |
v27 | 2022-09-30 | English | Compare |
v26 | 2022-09-20 | French | Compare |
v25 | 2022-09-20 | English | Compare |
v24 | 2022-09-01 | French | Compare |
v23 | 2022-09-01 | English | Compare |
v22 | 2022-08-05 | French | Compare |
v21 | 2022-08-05 | English | Compare |
v20 | 2022-07-28 | French | Compare |
v19 | 2022-07-28 | English | Compare |
v18 | 2022-06-30 | French | Compare |
v17 | 2022-06-30 | English | Compare |
v16 | 2022-06-20 | French | Compare |
v15 | 2022-06-20 | English | Compare |
v14 | 2022-06-01 | French | Compare |
v13 | 2022-06-01 | English | Compare |
v12 | 2022-05-13 | French | Compare |
v11 | 2022-05-13 | English | Compare |
v10 | 2022-05-06 | French | Compare |
v9 | 2022-05-06 | English | Compare |